JANX
Janux Therapeutics Inc
16.70$
+1.0%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 91.8% | 91.8% | 95.6% | 95.7% | 95.9% | 97.4% | 97.4% | 97.4% | 97.4% | 96.9% | 97.5% | 97.6% | |
| 4.4% | 5.0% | 30.9% | 2.1% | 3.8% | 40.6% | 7.0% | 5.1% | 4.7% | 5.2% | 5.0% | 2.8% | |
| 90.4% | 90.4% | 94.6% | 93.5% | 94.7% | 96.6% | 96.5% | 96.5% | 96.5% | 95.9% | 93.0% | 96.4% | |
| 0.4% | 0.6% | 0.6% | 1.7% | 0.6% | 0.5% | 0.5% | 0.6% | 0.6% | 0.6% | 4.1% | 0.6% | |
| -0.4% | -0.6% | – | 0.0% | – | – | – | – | – | – | – | – | |
| 9.8% | 9.5% | 4.8% | 4.9% | 5.6% | 3.6% | 3.6% | 4.0% | 4.7% | 5.0% | 8.4% | 7.9% | |
| 3.7% | 3.4% | 1.5% | 1.7% | 2.5% | 1.6% | 1.7% | 2.1% | 2.7% | 2.5% | 5.7% | 6.0% | |
| 0.4% | 0.4% | 0.2% | 0.2% | 0.2% | 0.2% | 0.2% | 0.2% | 0.2% | 0.2% | 0.2% | 0.3% | |
| 0.6% | 0.6% | 0.3% | 0.2% | 0.4% | 0.4% | 0.2% | 0.3% | 0.3% | 0.5% | 0.3% | 0.3% | |
| 90.2% | 90.5% | 95.2% | 95.1% | 94.4% | 96.4% | 96.4% | 96.0% | 95.3% | 95.0% | 91.6% | 92.1% | |
| -40.6% | -44.4% | -26.6% | -27.4% | -31.3% | -22.4% | -24.9% | -28.6% | -31.2% | -34.9% | -36.5% | -39.5% | |
| 11.8% | 12.3% | 7.1% | 7.9% | 7.9% | 5.4% | 5.9% | 6.0% | 6.1% | 6.2% | 6.1% | 6.2% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.